| Application no. and date | 04798717.7 (espacenet) (Federated) (European Patent Register), 20041115 | | Patent/reg. no. and date | DK/EP 1689404, 20080903 | | Publication date | 20060816 | | Priority no. and date | US 519690 P, 20031113 | | EP pub. no. and date |
EP 1689404 20060816 | | Effective date | | | Applicant/owner | Pharma Mar, S.A.U., Poligono Industrial La Mina
Avda. de los Reyes, 1
Colmenar Viejo
28770 Madrid, ES | | Applicant ref. no. | 08185-2 | | Inventor | RYBAK, Mary, Ellen, 3 Stout Road
Princeton, NJ 08540, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/498 (2006.01) , A61K 31/513 (2006.01) , A61K 31/7068 (2006.01) , A61P 35/00 (2006.01) | | Title | Kombination af et-743 med 5-fluoracil-prodrugs til behandling af cancer | | Int. application no. | GB2004050026 | | Int. publication no. | WO2005049031 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
